Walter J. Aspatore, Chairman

Mr. Aspatore has served as Chairman Emeritus of Amherst Partners, LLC, a business-consulting firm, since 2010. Prior thereto, Mr. Aspatore was Chairman of Amherst Partners from 1994 through 2010. Mr. Aspatore has served as Chairman of our Board since September, 2012. Prior to co-founding Amherst Partners, Mr. Aspatore served in various officer positions at diversified manufacturing and technology businesses, including Cross and Trecker Corporation, the Warner and Swasey Company, Bendix Corporation and TRW Corporation. He also served as Vice Chairman and President of Onset BIDCO, a venture capital and subordinated debt fund, from 1992 to 1994. Mr. Aspatore also serves as a director of Mackinac Financial Corporation, a bank holding company. Mr. Aspatore’s consulting experience and service at various consulting, manufacturing and technology businesses has resulted in continued contributions to the Board.

David P. Blom, Director

Mr. Blom is currently a Director on the boards of Worthington Industries, SOC Telemed, Vizient and Healthy Roster. Mr. Blom recently retired as CEO of OhioHealth, having led its expansion in Ohio for sixteen years. He transformed the OhioHealth’s business model to improve operational efficacy, service and quality to ensure the community receives more affordable healthcare services. Under his leadership, OhioHealth has been on the Fortune “100 Best Companies to Work For” list for 12 straight years. Prior, Mr. Blom began with what is now known as OhioHealth in 1983, was promoted to Chief Operating Officer is 1999, and promoted to CEO three years later.

Therese Bobek, Director

Ms. Therese Bobek was an Assurance Partner of PricewaterhouseCoopers LLP (“PwC”) from 1997 until her retirement in 2018. She most recently served in PwC’s national office where she directed a nationwide network of partners and managers supporting audit quality in the field. Ms. Bobek has served as an Adjunct Lecturer in the Master of Accountancy Program at the University of Iowa’s Tippie College of Business since 2018 and serves on the Boards of Trustees and the Audit Committees of the Northern Funds and Northern Institutional Funds.

Brian J. Cadwallader, Director

Mr. Cadwallader served as Vice President, Corporate Secretary and General Counsel of Johnson Controls, Inc. from October 2014 to December 2016. Prior thereto, Mr. Cadwallader served as Vice President and Assistant General Counsel of Johnson Controls from September 2011 to September 2014. Mr. Cadwallader served as Group Vice President and General Counsel of Johnson Controls’ Building Efficiency business from August 2010 to September 2011. Prior to joining Johnson Controls, Mr. Cadwallader served as Associate General Counsel at International Paper Company. Mr. Cadwallader’s legal background and corporate governance and M&A expertise contribute to the Board.

Bruce K. Crowther, Director

Mr. Crowther most recently served as President and Chief Executive Officer at Northwest Community Healthcare for 23 years, an award-winning hospital offering a complete system of care in state-of-the-art facilities. He previously served as Vice President for Administration at Elmhurst Memorial Healthcare. Prior, Mr. Crowther worked as Director, Professional Services at the University of Illinois Hospital and Health Sciences and also as Director, Renal Services at Northwestern Memorial hospital. He brings a wealth of expertise in hospital administration and will be a tremendous asset supporting Dabir’s growth strategy.

Darren M. Dawson, Director

Dr. Dawson has served as the President of The University of Alabama in Huntsville since April, 2019. Prior thereto, Dr. Dawson served as Dean of the College of Engineering of Kansas State University since 2014. From 1990 to 2014, Dr. Dawson served as a Professor in the Electrical and Computer Engineering Department at Clemson University. His research interests included nonlinear control techniques for mechatronic systems, robotic manipulator systems and vision-based systems. Dr. Dawson’s work has been recognized by several awards, including the Clemson University Centennial Professorship in 2000. Dr. Dawson’s academic and technical background has provided the basis for continued contributions to the Board’s operations and deliberations.

Donald W. Duda, Director, President & CEO

Mr. Duda has served as Methode's Chief Executive Officer since May 2004 and Methode's President since 2001. Mr. Duda joined the Company in March 2000 and served as its Vice President of Interconnect Products Group. Prior to his service at Methode, Mr. Duda held several positions with Amphenol Corporation, a manufacturer of electronic connectors, most recently as General Manager of its Fiber Optic Products Division from 1988 through November 1998.

Isabelle C. Goossen, Director

Ms. Goossen served as the Chief Financial Officer for the Chicago Symphony Orchestra Association from 2011 thru 2017. Ms. Goossen served as the Vice President for Finance and Administration for the Chicago Symphony Orchestra Association from 2001 thru 2017. From 1986 through 1999, Ms. Goossen held several management positions with Premark International, Inc., most recently as Vice President and Treasurer. Ms. Goossen serves as a director of the Columbian Financial Group, the parent company of Columbian Mutual Life Insurance and Columbian Life Insurance Company, each a life insurance company. In addition, Ms. Goossen is a trustee of Knox College and a director of the Cook County Health Foundation. Ms. Goossen has used her financial expertise and management background to make continued contributions to the Board.

Mary Lindsey, Director

Ms. Mary Lindsey served as Chief Financial Officer of Commercial Metals Company, a global manufacturer and recycler of steel and other metals, from January 2016 until her retirement in August 2019. In addition, Ms. Lindsey served as Senior Vice President since 2017 and Vice President-Tax from 2009 to 2016. Also, Ms. Lindsey spent twenty years at Timken starting as a Corporate Attorney and then moving into various roles, including business strategy, until her promotion to Vice President, Tax and Tax Counsel before departing in 2005. Ms. Lindsey currently serves as a Director and Chair of the Audit Committee of Lindsay Corporation, a provider of water management and road infrastructure products and services.

Angelo V. Pantaleo, Director

Mr. Pantaleo is Chairman and CEO of Marmon Holdings, Inc. Marmon, a Berkshire Hathaway subsidiary, is a global industrial organization comprising more than 125 diverse businesses with 2018 revenues of more than $8.1 billion. After joining Marmon in 1991, Mr. Pantaleo advanced to Group President over Marmon’s portfolio of water treatment and consumer products businesses. Beginning in 2014, he led the integration of Duracell into Berkshire Hathaway and served as Chairman and CEO of the global battery business until returning to Marmon in 2018. Before joining Marmon, he spent 11 years in progressive roles with DuPont.

Mark D. Schwabero, Director

Mr. Schwabero retired after 14 years at Brunswick Corporation, a market leader in the marine and fitness industries, most recently serving as Chairman and Chief Executive Officer. Prior, Mr. Schwabero worked as President and CEO of Hendrickson International, a leading manufacturer of heavy truck and trailer suspension systems and components, as well as President, Automotive Products Business and Regional President of Pilkington Libbey-Owens-Ford. His experience in complex global operations will bring valuable insight to help Methode drive value creation.

Lawrence B. Skatoff, Vice Chairman of the Board

Mr. Skatoff retired in 2001 as Executive Vice President and Chief Financial Officer of BorgWarner Inc., a manufacturer of highly engineered systems and components for the automotive industry. Prior to joining BorgWarner Inc., Mr. Skatoff was Senior Vice President and Chief Financial Officer of Premark International, Inc., a diversified consumer products company, from 1991 through 1999. Before joining Premark, Mr. Skatoff was Vice President-Finance of Monsanto Company, a worldwide manufacturer of chemicals and pharmaceuticals. Mr. Skatoff’s executive experience and financial background has led to continued contributions to the Board.